EUVIMEDEUVIMED entdecken
Leitlinie

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary

Julie R Brahmer, Christina Lacchetti, John A Thompson

Journal of Oncology Practice · 2018-04 · 14 (4) · 247-249

DOI: 10.1200/jop.18.00005 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Oncology Practice, 2018-04. Verfasst von Julie R Brahmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Kimmel Cancer Center, Baltimore, MD; American Society of Clinical Oncology, Alexandria, VA; University of Washington; and Fred Hutchins…. Die Arbeit wurde bisher 266-mal zitiert (Crossref) und nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, ImmunologicalBiomarkers, TumorDisease ManagementDrug-Related Side Effects and Adverse ReactionsHumansMolecular Targeted TherapyNeoplasms

Substanzen

Antineoplastic Agents, ImmunologicalBiomarkers, Tumor

Autor:innen und Institutionen

  • Johns Hopkins Kimmel Cancer Center, Baltimore, MD; American Society of Clinical Oncology, Alexandria, VA; University of Washington; and Fred Hutchinson Cancer Research Center, Seattle, WA.

Zitieren

APA

Brahmer, J. R., Lacchetti, C., & Thompson, J. A. (2018). Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary. Journal of Oncology Practice, 14(4), 247-249. https://doi.org/10.1200/jop.18.00005

Vancouver

Brahmer JR, Lacchetti C, Thompson JA. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary. Journal of Oncology Practice. 2018;14(4):247-249. doi:10.1200/jop.18.00005

BibTeX
@article{Brahmer2018,
  author = {Brahmer, Julie R and Lacchetti, Christina and Thompson, John A},
  title = {Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary},
  journal = {Journal of Oncology Practice},
  year = {2018},
  volume = {14},
  number = {4},
  pages = {247--249},
  doi = {10.1200/jop.18.00005}
}
Kostenlos starten →